# Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

> **NCT03425799** · PHASE3 · TERMINATED · sponsor: **Exela Pharma Sciences, LLC.** · enrollment: 5 (actual)

## Conditions studied

- Spinal Fusion

## Interventions

- **DRUG:** Sodium Chloride 0.9% Inj
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03425799
- **Lead sponsor:** Exela Pharma Sciences, LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-17
- **Primary completion:** 2019-10-23
- **Final completion:** 2020-01-21
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low recruitment rate
- **Last updated:** 2021-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425799, "Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03425799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*